Weis Markets posted Q2 net income of USD 22.86 million, down 9.6% year over year; EPS slipped to USD 0.92.
Total revenue rose 4.6% to USD 1.28 billion; comparable store sales increased 2.3% year over year.
Pharmacy revenue growth was hit by about USD 10.71 million from Inflation Reduction Act Medicare maximum fair price provisions effective Jan. 1, 2026.
Year-to-date net income climbed 13.1% to USD 50.71 million; total revenue increased 4.6% to USD 2.53 billion.
Management cited higher promotional and targeted loyalty-marketing investment, while maintaining strong in-stock levels and a consistent shopping experience.
WMK•
